2024-513234-37-00已完成1 期
A study investigating the safety, absorption, and elimination of radioactively labeled RO7269162, a new compound that may potentially be used in the treatment of Alzheimer’s disease.
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Trial Information System -TISL
Scientific
F. Hoffmann-La Roche AG
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A study investigating the safety, absorption, and elimination of NNC0705-0001, a new compound that could potentially be used in the treatment of cardiometabolic diseases caused by inflammation.2024-519478-38-00Novo Nordisk A/S116
已完成
不适用
A study for evaluating the safety of the intake of a test food for healthy adults.JPRN-UMIN000032670TTC Co.,Ltd20
已完成
Unknown
A study for evaluating the safety of the intake of a test food.Healthy adultJPRN-UMIN000045361EP Mediate Co., Ltd.48
已完成
不适用
A study for evaluating the safety of the intake of a test food for constipation tendency adults.oneJPRN-UMIN000030556TTC Co.,Ltd10
进行中（未招募）
1 期
A Study to assess the safety, efficacy and tolerability of Rituximab(Mabthera) in combination with Plasma Exchange in patients with Acute Thrombotic Thrombocytopenia Purpura. - The use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura.Thrombotic Thrombocytopenia PurpuraEUCTR2005-002274-30-GBniversity College London40